Prediction of pathological complete response (pCR) by Homologous Recombination Deficiency (HRD) after carboplatin-containing neoadjuvant chemotherapy in …

G Von Minckwitz, K Timms, M Untch, EP Elkin… - 2015 - ascopubs.org
1004 Background: We previously showed that adding carboplatin to paclitaxel/liposomal
doxorubicin (PM) can improve pCR rates in patients with TNBC at the cost of added toxicity …
被引用次数：54 相关文章

[引用][C] Prediction of pathological complete response (pCR) by Homologous Recombination Deficiency (HRD) after carboplatin-containing neoadjuvant chemotherapy …

G Von Minckwitz, K Timms, M Untch, EP Elkin… - Journal of Clinical …, 2015 - cir.nii.ac.jp
Prediction of pathological complete response (pCR) by Homologous Recombination Deficiency
(HRD) after carboplatin-containing neoadjuvant chemotherapy in patients with TNBC: Results …

[引用][C] Prediction of pathological complete response (pCR) by Homologous Recombination Deficiency (HRD) after carboplatin-containing neoadjuvant chemotherapy …

G von Minckwitz, K Timms, M Untch, EP Elkin… - 2015 - mediatum.ub.tum.de
mediaTUM - Medien- und Publikationsserver mediaTUM Universitätsbibliothek Technische
Universität München Logo Benutzer: Gast Login de en Erweiterte Suche mediaTUM …